Clinical Trials Directory

Trials / Sponsors / Biocon Limited

Biocon Limited

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedComparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U
Healthy Volunteers
Phase 12022-05-30
CompletedEfficacy and Safety of Itolizumab in COVID-19 Complications
Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Covid19
Phase 22020-05-01
TerminatedEvaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil
Type 1 Diabetes Mellitus (T1DM)
Phase 12019-10-28
CompletedComparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R
Healthy Volunteer
Phase 12019-06-18
CompletedComparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N
Healthy Volunteer
Phase 12019-06-15
CompletedComparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30
Healthy Volunteer
Phase 12019-06-15
CompletedComparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients
Type2 Diabetes Mellitus
Phase 2 / Phase 32017-12-26
CompletedEffect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD
Type 2 Diabetes Mellitus
Phase 12014-03-27
TerminatedSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patien
Type 1 Diabetes Mellitus
Phase 12010-08-21